Urinary System Neoplasm — Trials

Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 119 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03732677	Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC(NIAGARA)	active not recruiting	Phase 3	1,063	AstraZenecaINDUSTRY	22	Jul 17, 2026	clinicaltrials
NCT05078047	Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO(MOIO)	active not recruiting	Phase 3	646	UNICANCEROTHER	1